UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
February 2, 2004
ULTRALIFE BATTERIES, INC.
____________________________________________________
(Exact name of registrant as specified in its charter)
Delaware
____________________________________________________________
(State or other jurisdiction of incorporation or organization)
0-20852 16-1387013
______________________ __________________________________
(Commission File Number) (I.R.S. Employer Identification No.)
2000 Technology Parkway, Newark, New York 14513
_________________________________________________
(Address of principal executive offices) (Zip Code)
(315) 332-7100
__________________________________________________
(Registrant's telephone number, including area code)
Item 7. Financial Statements, Pro Forma Financials and Exhibits.
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
99.1 Press Release dated February 2, 2004
Item 9. Regulation FD Disclosure.
The Company announced that it has been awarded a production contract for its
BA-5390/U battery valued at approximately $12 million, by the U.S. Army
Communications Electronics Command (CECOM). Battery shipments are expected to
begin in the second quarter and be completed during the third quarter of this
year. Refer to the attached Exhibit 99.1 for the entire text of the release,
which Exhibit is being furnished but not filed in accordance with Regulation FD.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ULTRALIFE BATTERIES, INC.
Dated: February 2, 2004 By: /s/ Peter F. Comerford
_____________________________________
Peter F. Comerford
Vice President - Administration &
General Counsel
Index to Exhibits
(99) Additional Exhibits
99.1 Press Release dated February 2, 2004
Exhibit 99.1
Ultralife Batteries, Inc. Awarded $12 Million Army Battery Contract
NEWARK, N.Y.--(BUSINESS WIRE)--Feb. 2, 2004--Ultralife Batteries,
Inc. (Nasdaq:ULBI) has been awarded a production contract for its
BA-5390/U battery valued at approximately $12 million, by the U.S.
Army Communications Electronics Command (CECOM). Battery shipments are
expected to begin in the second quarter and be completed during the
third quarter of this year.
John D. Kavazanjian, Ultralife's president and chief executive
officer, said, "This order builds on the steady stream of BA-5390
battery contract awards that we received throughout 2003, and
reinforces our ability to maintain volume production with a high level
of manufacturing efficiency. It also reflects the continuing demand
from the Army for the superior performance and cost effectiveness of
our battery system."
This contract announcement is not related to the Next Gen II Phase
IV, 5-year battery procurement for this and other rectangular military
batteries, the solicitation for which was recently released by CECOM.
Ultralife will participate in this procurement through the competitive
bidding process, which is expected to begin in the first quarter of
this year.
The BA-5390/U is a lithium/manganese dioxide primary
(non-rechargeable) battery, and, with 50 percent more energy, is an
alternative to the lithium/sulfur dioxide BA-5590/U battery, the most
widely used military battery in the U.S. Armed Forces. The BA-5390/U
is widely used to power more than 50 military applications, such as
the AN/PRC-119 SINCGARS (Single Channel Ground and Airborne Radio
System) and the Javelin Medium Anti-Tank Missile Command Launch Unit.
The BA-5390/U provides soldiers with the latest and best battery
technology in a cost effective manner. More energy in each battery
provides longer mission time with fewer batteries for soldiers to
carry, and fewer batteries to ship and dispose of, all of which reduce
cost to the Army.
About Ultralife Batteries, Inc.
Ultralife is a leading developer, manufacturer, and marketer of
standard and customized lithium primary (non-rechargeable), lithium
ion and lithium polymer rechargeable batteries. Ultralife's
high-energy batteries use advanced lithium technology and are used in
military, industrial and consumer portable electronic products.
Through its range of standard products and ability to customize for a
wide range of applications, Ultralife is able to provide the next
generation of battery solutions. OEM, retail and government customers
include Energizer, Kidde Safety, Philips Medical Systems, Radio Shack
and the national defense agencies of the United States and United
Kingdom, among others.
Ultralife's headquarters, principal manufacturing and research
facilities are in Newark, New York, near Rochester. Ultralife (UK)
Ltd., a second manufacturing and research facility, is located in
Abingdon, U.K. Both facilities are ISO-9001 certified.
This press release may contain forward-looking statements based on
current expectations that involve a number of risks and uncertainties.
The potential risks and uncertainties that could cause actual results
to differ materially include: worsening global economic conditions,
increased competitive environment and pricing pressures, disruptions
related to restructuring actions and delays. Further information on
these factors and other factors that could affect Ultralife's
financial results is included in Ultralife's Securities and Exchange
Commission (SEC) filings, including the latest Annual Report on Form
10-K.
Detailed information on Ultralife is available at the Company's
Web site, www.ultralifebatteries.com.
Note to Editors: Ultralife(R) is a registered trademark of
Ultralife Batteries, Inc.
CONTACT: Ultralife Batteries, Inc.
Robert Fishback, 315-332-7100
rfishback@ulbi.com
or
Investor Relations Contact:
Lippert/Heilshorn & Associates, Inc.
Jody Burfening, 212-838-3777
jks@lhai.com
or
Media Contact:
Lippert/Heilshorn & Associates, Inc.
Chenoa Taitt, 212-201-6635
ctaitt@lhai.com